Radotinib HCl not checked

Il-Yang Pharm. Co., Ltd. · IY5511

FollowEvery change as it happens, and a Monday email
Stage
in other
Next date
Phase 3 trial completes
Trials
3 active
4 in total · 1 in the EU
Targets
 

What this is

How it works
Blocks a kinase, an enzyme that passes "grow" or "activate" signals inside cells. Most are cancer drugs.-tinib: tyrosine kinase inhibitors WHO name stem
How it’s given
“Patients randomized to the radotinib arms will receive 300 mg of radotinib BID (1 in the morning and 1 in the evening, at approximately 12-hour intervals).”In the company’s words, NCT03722420 on ClinicalTrials.gov
Tested for
Chronic Myeloid Leukemia, Chronic Phase (2 trials), CML, Chronic Phase, CML, Refractory, CML - Philadelphia Chromosome, Parkinson Disease
Main trialPhase 3
“This is a Phase III, multi-center, open-label, parallel, 2-arm, randomized study to evaluate the efficacy and safety of radotinib 300 mg Bis In Die(BID) versus imatinib 400 mg Quaque Die(QD). This study will be conducted in Chinese patients with newly diagnosed Ph+ Chronic Myelogenous Leukemia(CML)-Chronic Phase(CP) who are previously untreated for Chronic Myelogenous Leukemia(CML).”In the company’s words, NCT03722420 on ClinicalTrials.gov
Other names
SUPECT · Radotinib · IY5511

Other drugs for Chronic Myeloid Leukemia, Chronic Phase

All 9 drugs for Chronic Myeloid Leukemia, Chronic Phase

Coming up1

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials4

TrialPhaseCompletesWhat it tests
Phase 3Active, not recruiting 3 Mar 2023 Randomized Evaluation of Radotinib Versus Imatinib in Phase III Study for Efficacy With Chinese Patients (RERISE China)
Phase 3Recruiting 30 Jun 2027 A Phase 3 Study for the Efficacy and Safety of Radotinib in CP-CML Patients With Failure or Intolerance to Previous TKIs
Phase 2Active, not recruiting 2 Sep 2026 Safety, Tolerability, Pharmacokinetics and Efficacy Study of Radotinib in Parkinson's Disease
Phase 1Completed 25 Sep 2024 Clinical Trial to Investigate the Effects of Food on the Pharmacokinetics and Safety of Orally Administered Radotinib
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026

Follow Radotinib HCl

Following is part of Solo: you see every change to Radotinib HCl the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in